博雅生物(300294)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300294 博雅生物

交易中 05-15 11:16:00

{"stockData":{"symbol":"300294","market":"SZ","secType":"STK","nameCN":"博雅生物","latestPrice":34.47,"timestamp":1715742960000,"preClose":34.47,"halted":0,"volume":1180550,"delay":0,"floatShares":426000000,"shares":504000000,"eps":0.4347,"marketStatus":"交易中","marketStatusCode":2,"change":0,"latestTime":"05-15 11:16:00","open":34.38,"high":34.76,"low":34.16,"amount":40639900,"amplitude":0.0174,"askPrice":34.48,"askSize":42,"bidPrice":34.47,"bidSize":7,"shortable":0,"etf":0,"ttmEps":0.4347,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1715743800000},"adr":0,"adjPreClose":34.47,"symbolType":"stock","openAndCloseTimeList":[[1715736600000,1715743800000],[1715749200000,1715756400000]],"highLimit":37.92,"lowLimit":31.02,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":504248738,"pbRate":2.33,"roa":"--","roe":"2.06%","epsLYR":0.47,"committee":-0.333333,"marketValue":17381000000,"floatMarketCap":14682000000,"peRate":79.296064,"changeRate":0,"turnoverRate":0.0028,"status":2},"requestUrl":"/m/hq/s/300294","defaultTab":"news","newsList":[{"id":"2434821870","title":"肝素概念盘中拉升，博雅生物涨0.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434821870","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2434821870?lang=zh_cn&edition=full","pubTime":"2024-05-09 09:39","pubTimestamp":1715218788,"startTime":"0","endTime":"0","summary":"05月09日，肝素概念盘中拉升，截至09点39分，肝素概念整体指数上涨0.60%，报760.050点。从个股上来看，该概念的成分股中，博雅生物涨0.75%，*ST景峰、华润双鹤、辰欣药业涨幅居前。从资金上来看，截止发稿，肝素概念主力净流入为-2287.86万，其中华润双鹤受到资金热捧，主力净流入136.10万；拉长时间线来看，该板块近20日主力资金净流入-3.45亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240509093948861ebe3b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240509093948861ebe3b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430844816","title":"中邮证券：给予博雅生物买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2430844816","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430844816?lang=zh_cn&edition=full","pubTime":"2024-04-25 10:51","pubTimestamp":1714013495,"startTime":"0","endTime":"0","summary":"中邮证券有限责任公司蔡明子,陈成近期对博雅生物进行研究并发布了研究报告《一季度业绩符合预期，全年采浆量有望加速提升》，本报告对博雅生物给出买入评级，当前股价为31.45元。剔除23Q1经销业务和糖尿病业务对收入和利润端影响，2024Q1公司血制品业务预计同比实现平稳增长。首次覆盖，给予“买入”评级。最新盈利预测明细如下：该股最近90天内共有8家机构给出评级，买入评级8家；过去90天内机构目标均价为34.35。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042500023213.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430649284","title":"博雅生物（300294）2024年一季报简析：净利润减10.74%，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2430649284","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430649284?lang=zh_cn&edition=full","pubTime":"2024-04-25 06:13","pubTimestamp":1713996822,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期博雅生物发布2024年一季报。根据财报显示，本报告期中博雅生物净利润减10.74%，盈利能力上升。截至本报告期末，公司营业总收入4.48亿元，同比下降44.36%，归母净利润1.52亿元，同比下降10.74%。华润博雅生物是其大健康领域的血液制品平台，在华润集团的战略地位逐渐提升，资源配置更趋精准。为确保华润博雅生物的持续发展，华润医药层面成立了专项工作组，紧密跟进各项工作进展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042500011967.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429515455","title":"博雅生物：公司根据证券法规等要求，真实、准确、完整披露定期报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2429515455","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429515455?lang=zh_cn&edition=full","pubTime":"2024-04-24 21:00","pubTimestamp":1713963658,"startTime":"0","endTime":"0","summary":"证券之星消息，博雅生物(300294)04月24日在投资者关系平台上答复投资者关心的问题。投资者：您好，贵公司近日披露了一季度经营业绩，能否再详细披露一下血制品等各业务板块经营数据及同比情况？博雅生物董秘：您好，非常感谢您对本公司的关注。公司根据证券法规等要求，真实、准确、完整披露定期报告。谢谢！以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042400044718.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429026701","title":"华润医药：华润博雅生物一季度净利润1.522亿元 同比减少12.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429026701","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429026701?lang=zh_cn&edition=full","pubTime":"2024-04-24 14:19","pubTimestamp":1713939580,"startTime":"0","endTime":"0","summary":"华润医药(03320)发布公告，该公司附属华润博雅生物截至2024年3月31日止3个月取得营业总收入4.48亿元，同比减少44.36%;净利润1.52亿元，同比减少12.97%。 ...","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20240424/c657226860.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429713981","title":"血液制品概念盘中拉升，博雅生物涨3.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429713981","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429713981?lang=zh_cn&edition=full","pubTime":"2024-04-24 10:10","pubTimestamp":1713924633,"startTime":"0","endTime":"0","summary":"04月24日，血液制品概念盘中拉升，截至10点10分，血液制品概念整体指数上涨0.52%，报740.550点。从个股上来看，该概念的成分股中，博雅生物涨3.53%，同方股份、赛伦生物、宝莱特涨幅居前。从资金上来看，截止发稿，血液制品概念概念主力净流入为-899.05万，其中同方股份受到资金热捧，主力净流入1083.83万；拉长时间线来看，该板块近20日主力资金净流入-2.75亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404241010347a55109c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404241010347a55109c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429176691","title":"华润医药(03320.HK)附属博雅生物(300294.SZ)首季赚1.52亿人币  倒退近13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429176691","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2429176691?lang=zh_cn&edition=full","pubTime":"2024-04-24 09:37","pubTimestamp":1713922620,"startTime":"0","endTime":"0","summary":"华润医药(03320.HK) 公布，附属博雅生物(300294.SZ) 截至2024年3月31日止首季的未经审核财务业绩。根据中国公认会计准则，营业总收入4.48亿人民币(下同)，按年下跌44.35%。净利润1.52亿元，倒退近13%。(js/da)(港股报价延迟最少十五分钟。沽空资料截至 2024-04-23 16:25。) (A股报价延迟最少十五分钟。)AASTOCKS新闻","market":"sh","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20190604131528273_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20190604131528273_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1344517/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2429255281","title":"华润医药(03320)：华润博雅生物一季度净利润1.522亿元 同比减少12.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429255281","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429255281?lang=zh_cn&edition=full","pubTime":"2024-04-24 06:14","pubTimestamp":1713910479,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华润医药(03320)发布公告，该公司附属华润博雅生物截至2024年3月31日止3个月取得营业总收入4.48亿元，同比减少44.36%;净利润1.52亿元，同比减少12.97%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1108142.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429610711","title":"博雅生物最新公告：一季度净利润1.52亿元 同比下降10.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429610711","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429610711?lang=zh_cn&edition=full","pubTime":"2024-04-23 18:11","pubTimestamp":1713867067,"startTime":"0","endTime":"0","summary":"博雅生物公布2024年一季度报告，报告期营业收入4.48亿元，同比下降44.36%；归属于上市公司股东的净利润1.52亿元，同比下降10.74%；基本每股收益0.30元。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042300035759.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429169204","title":"博雅生物(300294.SZ)发布一季度业绩，净利润1.52亿元，下降10.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429169204","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2429169204?lang=zh_cn&edition=full","pubTime":"2024-04-23 17:49","pubTimestamp":1713865743,"startTime":"0","endTime":"0","summary":"智通财经APP讯，博雅生物(300294.SZ)发布2024年一季度报告，报告期内实现营业收入4.48亿元，同比下降44.36%。归属于上市公司股东的净利润1.52亿元，同比下降10.74%。归属于上市公司股东的扣除非经常性损益的净利润1.27亿元，同比下降7.63%。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1107614.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2422581713","title":"【港股通】华润医药(03320)：华润博雅生物去年溢利降45.06%至2.37亿元人民币 拟10派3元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422581713","media":"金吾财讯","top":-1,"share":"https://www.laohu8.com/m/news/2422581713?lang=zh_cn&edition=full","pubTime":"2024-03-25 08:30","pubTimestamp":1711326619,"startTime":"0","endTime":"0","summary":"金吾财讯 | 华润医药(03320)公布，2023年度，公司附属公司华润博雅生物上市公司股东应占净利润2.37亿元(人民币，下同)，同比减少45.06%；每股基本盈利0.47元，同比减少45.35%。经华润博雅生物董事会决定，华润博雅生物建议以实施权益分派股权登记日登记的总股本为基数，向全体华润博雅生物股东分派现金股息每10股人民币3元(含税)。期内，华润博雅生物实现营业总收入26.52亿元，同比减少3.87%。","market":"other","thumbnail":"https://static.szfiu.com/news/20210810/NzE2MmQxNjEyNzIzMzUyNjY5.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NzE2MmQxNjEyNzIzMzUyNjY5.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1933913","is_publish_highlight":false,"gpt_icon":0},{"id":"2419656346","title":"华润医药(03320.HK)附属华润博雅生物去年赚2.37亿人民币  跌45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419656346","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2419656346?lang=zh_cn&edition=full","pubTime":"2024-03-14 02:19","pubTimestamp":1710353940,"startTime":"0","endTime":"0","summary":"华润医药(03320.HK) 公布，附属华润博雅生物2023年度业绩快报，营业总收入26.52亿人民币(下同)，按年下3.9%。归属股东净利润2.37亿元，倒退45.1%，每股收益0.47元。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2024-03-13 16:25。)过往派息公布日期派息事项派息内容2023/10/31第三季业绩无派息2023/08/31中期业绩无派息2023/03/30末期业绩普通股息：港元 0.1600(相当于人民币 0.1400)2022/08/25中期业绩无派息 AASTOCKS新闻","market":"fut","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20210624132643819_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20210624132643819_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1333225/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2419368304","title":"博雅生物(300294.SZ)：2023年度净利润2.37亿元 同比下降45.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419368304","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2419368304?lang=zh_cn&edition=full","pubTime":"2024-03-13 20:10","pubTimestamp":1710331800,"startTime":"0","endTime":"0","summary":"博雅生物披露2023年度业绩快报，该公司报告期实现营业总收入26.52亿元，同比下降3.87%。归属于上市公司股东的净利润2.37亿元，同比下降45.06%。基本每股收益为0.47元/股。2023年实现血液制品业务营业收入和净利润稳步增长。此外，2023年公司归属于上市公司股东的净利润较上年同期减少45.06%，主要系计提收购南京新百药业有限公司形成的商誉减值准备2.98亿元及其他资产减值准备影响。股市回暖，抄底炒股先开户！智能定投、条件单、个股雷达……","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-13/doc-inaneseq8710213.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-13/doc-inaneseq8710213.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2384535960","title":"博雅生物(300294.SZ)单采血浆站取得营业执照","url":"https://stock-news.laohu8.com/highlight/detail?id=2384535960","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2384535960?lang=zh_cn&edition=full","pubTime":"2023-11-20 16:22","pubTimestamp":1700468520,"startTime":"0","endTime":"0","summary":"博雅生物(300294.SZ)公告，公司下属单采血浆站“泰和博雅单采血浆有限公司”(“泰和浆站”)和“乐平市博雅单采血浆有限公司”(“乐平浆站”)取得市场监督管理局颁发的《营业执照》。泰和浆站、乐平浆站均为公司全资子公司，上述浆站将按照相关法律法规及标准要求进行建设，建成后根据《单采血浆站管理办法》等有关要求提交执业申请，经验收合格后开展采浆工作。\n\n现在送您60元福利红包，直接提现不套路~~~快来参与活动吧！\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-11-20/doc-imzvharr4102477.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-11-20/doc-imzvharr4102477.shtml","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2012-03-08","address":"江西省抚州市临川区高新技术产业园区惠泉路333号","stockEarnings":[{"period":"1week","weight":0.0423},{"period":"1month","weight":0.1609},{"period":"3month","weight":0.2556},{"period":"6month","weight":0.0941},{"period":"1year","weight":-0.0545},{"period":"ytd","weight":0.0334}],"companyName":"华润博雅生物制药集团股份有限公司","boardCode":"AI0027","perCapita":"23281股","boardName":"医药制造业","registeredCapital":"50424万元","compareEarnings":[{"period":"1week","weight":-0.0006},{"period":"1month","weight":0.0418},{"period":"3month","weight":0.0977},{"period":"6month","weight":0.0311},{"period":"1year","weight":-0.0498},{"period":"ytd","weight":0.0574}],"survey":"　　华润博雅生物制药集团股份有限公司的主营业务以血液制品为主，集生化药、化学药、原料药为辅。公司的主要产品为血液制品业务、天安药业的糖尿病用药业务、新百药业的生化类用药业务、博雅欣和化学药业务、复大医药经销业务。公司是全国较早通过国家药品新版GMP认证的企业之一，公司生产线采用过程自动控制系统对生产过程进行控制，实现了全程CIP、SIP及关键参数的自动记录。公司严格按国家相关规定组织生产和质量控制，大大提高了产品安全性、质量可控性，产品质量指标高于国家标准。","serverTime":1715742964258,"listedPrice":25,"stockholders":"18295人(较上一季度减少5.35%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"博雅生物(300294)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供博雅生物(300294)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"博雅生物,300294,博雅生物股票,博雅生物股票老虎,博雅生物股票老虎国际,博雅生物行情,博雅生物股票行情,博雅生物股价,博雅生物股市,博雅生物股票价格,博雅生物股票交易,博雅生物股票购买,博雅生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"博雅生物(300294)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供博雅生物(300294)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}